How many studies have been conducted on Gemtuzumab?

BiohacksAI has indexed 297 PubMed studies on Gemtuzumab, including 16 randomized controlled trials (RCTs). 74% of studies involve human subjects.

What are the main research areas for Gemtuzumab?

The primary research domains for Gemtuzumab are 🔬 Oncology, 😴 Sleep, 🫁 Liver & Detox. This is based on analysis of 297 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Gemtuzumab

an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

297+ PubMed studies analyzed · 16 RCTs · Evidence Score: 53.5

Research Domains

Gemtuzumab has been studied across 8 research domains including 🔬 Oncology, 😴 Sleep, 🫁 Liver & Detox, ⚡ Energy & Fatigue, 🛡️ Immunity. The primary research focus is 🔬 Oncology with 26% of studies addressing this area.

Loading evidence profile...

This evidence profile for Gemtuzumab is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.